Clinical Trials Directory

Trials / Completed

CompletedNCT00531661

CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
550 (actual)
Sponsor
CardioMEMS · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multi-center, randomized, single-blind clinical trial conducted in the United States (US). The objective of the study is to evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects suffering from HF.

Conditions

Interventions

TypeNameDescription
DEVICEHF Pressure Measurement SystemA pressure sensor is intended to be implanted into the pulmonary artery at the time of Swan-Ganz catheterization.

Timeline

Start date
2007-09-01
Primary completion
2010-05-01
Completion
2014-11-01
First posted
2007-09-19
Last updated
2015-01-28
Results posted
2013-04-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00531661. Inclusion in this directory is not an endorsement.